Your browser doesn't support javascript.
loading
[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening]. / Recommandations françaises pour la réalisation et l'interprétation du test de la sueur dans le cadre du dépistage néonatal de la mucoviscidose.
Sermet-Gaudelus, I; Munck, A; Rota, M; Roussey, M; Feldmann, D; Nguyen-Khoa, T.
  • Sermet-Gaudelus I; Inserm U 845, centre de ressources et de compétences de la mucoviscidose, hôpital Necker, université René Descartes, 156, rue de Vaugirard, 75730 Paris, France. isabelle.sermet@nck.aphp.fr
Arch Pediatr ; 17(9): 1349-58, 2010 Sep.
Article en Fr | MEDLINE | ID: mdl-20719482
ABSTRACT
These guidelines aim to standardize the standard operating procedures for the sweat test in newborn cystic fibrosis (CF) screening. They have been implemented by the national Neonatal Screening working group of the French Federation for Cystic Fibrosis. It is recommended that the sweat test be performed when the infant weighs more than 3 kg and is at least 3 weeks of age. Sweat gland secretion is stimulated by transdermal administration of pilocarpine by iontophoresis. Sweat is preferentially collected in a Macroduct coil. Diagnosis of CF is based on the sweat chloride level. A sweat chloride level below 30 mmol/l very probably rules out CF; 60 mmol/l or higher supports the diagnosis of CF. Values between 30 and 60 mmol/l are considered abnormal.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sudor / Cloruros / Tamizaje Neonatal / Fibrosis Quística Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans / Infant / Newborn Idioma: Fr Año: 2010 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sudor / Cloruros / Tamizaje Neonatal / Fibrosis Quística Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans / Infant / Newborn Idioma: Fr Año: 2010 Tipo del documento: Article